“I lost 1kg per week in my first month of using it!”
Retatrutide
A triple-receptor research peptide studied for appetite regulation, body composition, and metabolic health.
“Within my first month, I noticed steadier weight change and felt much more in control of my portions.”
“My cravings felt quieter, and my clothes started fitting differently as the weeks went by.”
“I felt lighter and less driven by hunger, with gradual changes that kept building over time.”
Same-day delivery where available in Costa Rica.
Contact Purava to confirm availability and timing for your address.
What effects can I expect taking this product?
Retatrutide may support reduced appetite, lower blood-sugar levels, and gradual weight change over time. Individual results vary, and this product is labeled for research use only.
How does it work?
Retatrutide is being studied for activity at GLP-1, GIP, and glucagon receptors, pathways involved in appetite, glucose regulation, and energy balance.
Shipping & storage information
Orders are handled with care and delivered same-day across Costa Rica where available.
Safety & important information
Review product labels and consult a qualified professional for any personal guidance.
Product Reviews
Experiences & Reviews.
Research, product details, and customer perspectives.
Google ReviewsUnderstanding the research
A Triple-Receptor Approach.
The Problem
Three Receptors.
One Research Focus.
Retatrutide is being studied across appetite regulation, body composition, and metabolic health research.
Appetite and metabolic signaling research.
Investigated alongside GLP-1 activity.
Studied as part of the combined receptor pathway.
Our Solution
Purava Retatrutide
10 MG
A Triple-Receptor Approach.
Retatrutide acts on GLP-1, GIP, and glucagon receptors. Clinical research explores how this combined activity affects appetite, body weight, and metabolic markers.
Three pathways.
One compound.
How it works
How Retatrutide Works
Retatrutide is designed to activate three hormone receptors involved in appetite, blood-sugar regulation, and energy balance. The combined signal may help the body feel fuller, regulate glucose, and use stored energy differently over time.
GLP-1 + GIP: Appetite and Glucose
These gut-hormone pathways signal fullness and can support glucose-dependent insulin release. That combination may reduce hunger, slow the movement of food through the stomach, and lower the rise in blood sugar after eating.
Glucagon: Energy Balance
Glucagon helps regulate how the liver releases fuel and how the body mobilizes stored energy. Retatrutide combines this signal with GLP-1 and GIP activity; researchers are studying how the three pathways work together to influence weight and metabolism.
Research reference: Jastreboff et al., NEJM 2023 — phase 2 retatrutide trial.
Three receptor signals. One combined effect on appetite, glucose, and energy balance. Individual responses vary.
Understanding the research
What You May Expect
Over Time
Retatrutide may affect appetite, blood-sugar regulation, and body weight progressively. These are approximate expectations—not promises, a personal treatment plan, or a substitute for medical guidance.
Appetite may begin to feel quieter, with smaller portions and fewer food thoughts feeling easier for some people.
As appetite patterns change, daily energy intake may become more consistent. Blood-sugar and insulin markers may also improve, especially when baseline levels are elevated.
Weight change typically builds over time rather than all at once. In clinical research, average reductions reached roughly 9%–24% by 48 weeks, depending on dose and participant response.
Some people continue to see gradual changes in body composition, appetite, and metabolic markers; others plateau or respond differently. Individual results vary.
Approximate expectations. Individual results vary.
How Retatrutide compares
How Retatrutide compares.
Meaningful weight change can be achieved through different approaches. Retatrutide’s research distinction is its combined activity at three hormone receptors involved in appetite and metabolism.
| Benefits | Retatrutide 10 MGThree pathways | Diet alone | Exercise alone | Tirzepatide |
|---|---|---|---|---|
| Clinical trial weight-loss evidence | ✓ | — | — | ✓ |
| Targets GLP-1 receptor signaling | ✓ | × | × | ✓ |
| Targets three hormone receptors | ✓ | × | × | × |
| Once-weekly schedule studied | ✓ | — | — | ✓ |
| Waist circumference tracked in research | ✓ | ✓ | ✓ | ✓ |
| Directly improves physical fitness | × | × | ✓ | × |
| Medication side-effect considerations apply | ✓ | — | — | ✓ |
| Approved obesity medication | × | — | — | ✓ |
Checks indicate a studied or established characteristic, not a guarantee of individual results. Retatrutide remains investigational; cross-trial comparisons are not proof of superiority.
Dosage Calculator
Find Your Reference Dose
Get an informational starting point based on supplied reference profiles, vial strength, and reconstitution volume. This is general education only, not medical advice.
Enter your details to calculate the draw volume.
General reconstitution math only.This calculator is for informational purposes only. Individual needs vary. Always consult with a qualified healthcare professional before starting any peptide protocol.
The Purava Promise
3rd-Party Batch Tested.
99%+ purity. COAs provided upon request.
Every batch is independently tested to verify purity and quality. Our products are formulated to a 99%+ purity standard, with certificates of analysis available upon request for added confidence.
High-standard formulations, independently verified.
Certificates of analysis available upon request.
Trusted third-party testing for added confidence.
Confidence In Every Batch
Recommended Products
Pairs Well With This Protocol.
Build a more complete routine with products selected around this product’s benefits and effects.
Questions?
Frequently Asked Questions
What is Retatrutide - 10 MG?
Retatrutide is an investigational agonist of GLP-1, GIP, and glucagon receptors, studied in metabolic and obesity research. Purava lists this 10 MG vial for research use only.
Is Retatrutide an approved weight-loss medication?
Retatrutide remains investigational. This Purava vial is labeled for research use only and is not an approved medicine for personal weight management.
Does 10 MG mean a single dose?
No. 10 MG identifies the labeled total amount in the vial, not a recommended personal dose. The calculator explains concentration math and does not prescribe treatment.
Where can I read the study?
The phase 2 trial is published in the New England Journal of Medicine: Triple-Hormone-Receptor Agonist Retatrutide for Obesity.
How quickly can this be delivered?
Purava offers same-day delivery across Costa Rica where available.
Are batch tests available?
Batch test documentation is available for selected products. Contact the Purava team for the latest details.
Can I speak to someone before ordering?
Yes. Contact the Purava team for product selection support.



